Potential Benefits of Second-Generation Human Papillomavirus Vaccines

BACKGROUND: Current prophylactic vaccines against human papillomavirus (HPV) target two oncogenic types (16 and 18) that contribute to 70% of cervical cancer cases worldwide. Our objective was to quantify the range of additional benefits conferred by second-generation HPV prophylactic vaccines that...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiatpongsan, Sorapop, Campos, Nicole Gastineau, Kim, Jane J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492348/
https://www.ncbi.nlm.nih.gov/pubmed/23144879
http://dx.doi.org/10.1371/journal.pone.0048426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492348/
https://www.ncbi.nlm.nih.gov/pubmed/23144879
http://dx.doi.org/10.1371/journal.pone.0048426

Ejemplares similares